2022

1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

   Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

2. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

   Journal of Clinical Oncology, Vol. 364